Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Esophageal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Carcinoma, Hepatocellular 3Neoplasm Metastasis 2Melanoma 2Esophageal Squamous Cell Carcinoma 2Advanced Solid Tumour 2Advanced Solid Tumor 2Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Solid Tumor 1Simpson-Golabi-Behmel syndrome 1Recurrence 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasm, Residual 1Nasopharyngeal Carcinoma 1Metastatic Solid Tumors 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Head and Neck Neoplasms 1Diabetes Mellitus 1Colorectal Neoplasms 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Advanced Solid Tumors 1Advanced Malignancies 1Adenocarcinoma Of Esophagus 1

Interventions

pembrolizumab 15Cisplatin 7Cetuximab 5dostarlimab 3Surveys and Questionnaires 3Carboplatin 3fludarabine 2abemaciclib 2Standard of Care 2Radiotherapy, Intensity-Modulated 2Paclitaxel 2Nivolumab 2Interviews as Topic 2Fulvestrant 2Docetaxel 2Cyclophosphamide 2Blood Specimen Collection 2130-nm albumin-bound paclitaxel 2ulixertinib 1trastuzumab deruxtecan 1toripalimab 1tislelizumab 1ribociclib 1repotrectinib 1patritumab deruxtecan 1palbociclib 1osimertinib 1olaparib 1niraparib 1nimotuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Head and Neck Neoplasms × tislelizumab × 30 days × Clear all
NCT07601737 2026-05-22

Nimotuzumab Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

Phase 2 Recruiting
182 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡